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Summary Plasmodium vivax (Pv) malaria is being increasingly recognized as a
cause of severe malaria in children.
Objectives: To describe the various severe manifestations associated with vivax
malaria by retrospective analysis of records.
Methods: Children between the ages of 0 and 18 years with a conﬁrmed diagnosis
of Pv malaria monoinfection done by peripheral blood ﬁlm (PBF) and/or rapid diag-
nostic test (RDT) admitted between June and September 2009 were included. Their
clinical, hematological and biochemical manifestations were analyzed.
Results: Twenty-three patients of Pv malaria were retrospectively analyzed. Throm-
bocytopenia was present in 22 (96%) patients with counts less than 50,000/L in 9
patients. Severe anemia (hgb < 5mg/dl) was present in 8 (34%) patients. Cerebral
malaria was present in 3 patients. Liver enzymes were elevated (>3 times normal)
in 4 (17.3%) patients while jaundice (bilirubin > 2.5mg/dl) was present in 2 patients
(total bilirubin 5.2mg/dl and 14.3mg/dl). Renal dysfunction (creatinine > 3mg/dl)
was present in 6 (26%) patients with 2 patients showing severely deranged renal func-
tions (blood urea 168mg/dl, 222mg/dl and serum creatinine 5.0mg/dl, 5.6mg/dl,
respectively). Hypernatremia was present in one patient. One patient expired within
12 h of presentation because of severely deranged hepatic and renal dysfunction.
Conclusion: Pv malaria can lead to unusual and fatal complications. All new guide-
lines should include ‘‘Severe Vivax malaria’’ as a clinical entity. Further research
into the etiopathogenesis and treatment would be important.
© 2011 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
Ltd. All rights reserved.∗ Corresponding author at: Room No. 20, New Registrar Block,
ady Hardinge Medical College, New Delhi 110001, India.
E-mail address: dr harpal81@yahoo.co.in (H. Singh).
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Introduction
Plasmodium vivax (Pv) also called as benign tertian
malaria accounts for more than 50% of infection
in South East Asia region [1]. Although it is usu-
ally associated with benign course recent literature
suggests that Pv can lead to serious manifestations
[2—12] similar to Plasmodium Falciparum (Pf). The
present report highlights the serious manifestation
of Pv malaria in children from India.
Methods
Case records of children between 0 and 18 years of
age with diagnosis of Pv malaria between June and
September 2009 were retrospectively analyzed.
Children with mixed infection with Pf/any other
malarial species or any other associated infection
were excluded. Diagnosis of Pv was conﬁrmed by
peripheral blood ﬁlm (PBF) examination and/or
rapid diagnostic test (RDT). Severe manifestations
of malaria [13] like seizure, jaundice, coma, severe
pallor, bleeding, oliguria, hypoglycemia, acidosis
and ARDS were reviewed. Routine hematological
and biochemical investigations were done in all
patients.
Results
Among 232 patients of malaria infection presented
to our hospital during study period, 110 (47%) were
of Pf monoinfection, 108 (46%) of Pv monoinfec-
tion and 14 (6%) of mixed infection. Thirty-two
patients of Pf monoinfection, 23 patients of Pv
monoinfection and 5 patients of mixed (Pf and Pv)
infection presented with severe manifestation were
admitted. The record of these 23 patients of Pv
f
o
o
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Table 1 Manifestations of severe malaria positive for Plasm
S. no. Manifestation
1 Severe anemia (<5mg/dl)
2 Thrombocytopenia (<150× 103/L)
3 Jaundice (bilirubin > 2.5mg/dl)
4 Renal failure (creatinine > 3mg/dl)
5 Cerebral malaria (Glasgow coma sco
6 Disseminated intravascular coagulat
7 Deranged liver enzymes (>3 fold ele
8 Leucocytosis (>12,000/cumm)
9 Persistent vomiting
10 Multi organ dysfunction
11 Repeated generalized convulsionsH. Singh et al.
onoinfection was retrospectively analyzed. Ten
44%) of these patients were female and mean age
f presentation was 5.4 years (±3.67) with range
rom 1 month to 12 years [<1 year 4 (17%); 1—5
ears 9 (39%); 5—10 years 7 (30%); >10 years 3
14%)]. Seventy percent of the children had moder-
te malnutrition (as per World Health Organization
lassiﬁcation) but there was no child with severe
alnutrition. In four patients PBF was negative but
DT was positive while one patient had positive PBF
ut negative RDT.
Gastrointestinal symptoms (diarrhea, vomiting)
ere present in signiﬁcant number (43.4%) of
atients while seizures presented in 4 (17.3%)
atients. Three patients with seizures had cere-
ral malaria but in fourth patient it was because of
ypernatremia (173meq/L). Hepatosplenomegaly
as present in all patients with mean size of liver
nd spleen being 2.7 cm (SD± 1.19 cm) and 2.4 cm
SD± 1.6 cm) below costal margins, respectively.
arious severe manifestations of vivax malaria
ave been described in Table 1. Severe anemia
<5mg/dl) was present in 8 (34%) cases. Throm-
ocytopenia (less than 150× 103/L) was a very
ommon (95.6%) manifestation while severe throm-
ocytopenia (<50× 103/L) was present in 9 (39%)
atients. Three patients who had platelet counts
ess than 10× 103/L presented with bleeding man-
festation in the form of petechiae and purpura
hich improved after platelet transfusion. Five
21%) patients presented with pancytopenia.
Two patients presented with jaundice. One of
hose had indirect hyperbilirubinemia (total bil.
.2mg/dl, indirect bil. 5.1mg/dl) with normal liver
nzymes (AST 35 IU/L, ALT 18 IU/L, ALP 240 IU/L)
ho improved subsequently. This patient had no
eature suggestive of hemolytic anemia in the form
f increased reticulocyte count, hemoglobinuria
r decreased haptoglobin. The one with direct
yperbilirubinemia (total bil. 14.3mg/dl, direct bil.
odium vivax.
No. (%) of patients (n = 23)
8 (34.7)
22 (95.6)
2 (8.6)
6 (26)
re < 9/14) 3 (13)
ion 1 (4)
vation) 4 (17.3)
3 (13)
4 (17.3)
1 (4)
4 (17.3)
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.3mg/dl) had severely deranged liver and renal
arameters. Liver enzymes were elevated (>3 fold
f normal) in 4 (17.3%) patients. Deranged coag-
lation parameters were present in two patients.
n one patient (INR-1.8, aPTT — 78 s) it improved
onservatively while in other (INR — 3.2, aPTT —
40 s) it required FFP (fresh frozen plasma) trans-
usion. Deranged renal functions (serum creatinine
2.5mg/dl) were present in 6 patients. One of
hese had complete renal shutdown (urine output
0.1ml/kg/h, serum creatinine −5.6mg/dl) and
equired peritoneal dialysis while other (urine out-
ut — 0.3ml/kg/h, serum creatinine — 5.0mg/dl)
mproved conservatively in 5 days. None of these
atients with renal involvement had albuminuria,
ematuria or hypertension. In one neonate cold
ntibody Coomb Test positive hemolytic anemia,
ith the peripheral smear showing Red blood cells
RBC) agglutinates around the parasitized RBC was
resent. We found no patient with hypoglycemia,
cidosis and acute respiratory distress syndrome
ARDS). Three patients presented with cerebral
alaria had seizures and altered sensorium without
ny focal neurological deﬁcit. Their cerebrospinal
uid examination ﬁndings were normal. Neuroimag-
ng (CECT Scan) showed diffuse cerebral edema
ithout any focal infarct or hypoattenuation.
All patients were treated with intravenous qui-
ine and supportive care as per standard guidelines.
epeat PBF after 2 days showed clearance of par-
site. Follow up which is routinely done in severe
alaria patients, showed no residual neurological
eﬁcit in any patient with cerebral malaria.
One nine-year-old boy expired with compli-
ation of Pv. This boy presented with severe
allor, GI bleeding and oliguria who had severely
eranged hepatic (AST 288 U/L, 340 U/L, total bil.
4.3mg/dl, direct bil. 6.7mg/dl) and renal func-
ions (urea 222mg/dl, creatinine 5.6mg/dl) with
bnormal coagulation proﬁle. The child developed
isseminated intravascular coagulation (platelet
ount 20× 103/L, INR — 3.2, aPTT — 140 s, D dimer
positive) and expired within 12 h of presentation.
iscussion
v which was initially thought to cause a mild
nfection with a benign course is now increasingly
eing recognized as a cause of severe malaria sim-
lar to Pf in adults and children including infants
14] and neonates [15]. Serious complications like
evere anemia [2], thrombocytopenia [3,4], bleed-
ng, jaundice, hepatic dysfunction [5—7], renal
ysfunction [8,9], cerebral malaria [10], ARDS [11],
i
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evere neutropenia, hydrocephalus [12] and multi-
rgan dysfunction [16,17] also have been reported
n children. All patients fulﬁlled the criteria of
evere malaria [13] except that the parasites seen
n PBS examination were of Pv and parasite load
as not determined.
Our clinical data strongly indicate that Pv
alaria can cause sequestration related compli-
ation of severe malaria like cerebral malaria,
epatic dysfunction, renal dysfunction, all of which
sually associated with Pf malaria. Other non-
equestration related complications like severe
nemia, thrombocytopenia, DIC are multifactorial,
ere more commonly seen. Possible mecha-
ism underlying the anemia includes hemolytic
ffect of parasites, decreased deforming capac-
ty of parasitized cells and parasite product
ediated effect on erythropoisis. Newer mecha-
isms like invasion of erythroblasts by parasites
ave also been reported [18]. Thrombocytopenia
as been attributed to increased splenic clear-
nce, reduction of platelet survival, decreased
latelet production and increased splenic uptake
f platelet. Immunological reaction [19] and oxida-
ive stress [20] are also suggested mechanisms of
hrombocytopenia.
Although derangement of liver enzymes was
common ﬁnding, severe malarial hepatitis was
ound in only one child. Malarial hepatitis is known
o be caused by direct injury to hepatocytes by the
arasite [5—7]. There may be a wide variety of renal
anifestation associated with malaria but these
re more common with Pf infection. Acute renal
ailure, electrolyte abnormality, increased urinary
rotein excretion and abnormal urinary sediments
ave been reported in patient with Pv malaria [8,9].
e also observed deranged renal functions in sig-
iﬁcant number of patients however severe renal
ailure was seen in only two patients.
Our results are similar to other published data
rom Indonesia, Pakistan and other studies from
ndia. In a large study from Papua New Guinea,
ndonesia which included both inpatient and
utpatients of malaria found that risk of severe
isease in the terms of severe anemia, respiratory
istress and coma were more common in Pv (23%)
s compared to Pf (20%) [21]. Another prospective
tudy conducted in two rural health facilities in
apua New Guinea reported 9537 cases of malaria,
he risk of severe malaria was comparable in Pv
nd Pf especially in children less than 5 years of
ge [22]. One more study from Indonesia which
ncluded 1560 infants of less than 3 months of age
f malaria. In these young infants, infection with Pv
as associated with a greater risk of severe anemia
odds ratio, 2.4; 95% CI 1.03—5.91) and severe
vR
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thrombocytopenia (odds ratio, 3.3; 95% CI
1.07—10.6) compared to PF [23]. A retrospec-
tive analysis of 221 patients of Pv malaria from
India by Sharma et al. [24] found thrombocy-
topenia, hepatic dysfunction, renal dysfunction in
signiﬁcant number of patients (96%, 27% and 7%,
respectively). Three maternal deaths occurred due
to ARDS. In another study from Bikaner (India) of
456 adult Pv malaria patients, 40 showed severe
manifestations. Complications observed were
hepatic dysfunction and jaundice in 23 (57.5%)
patients, renal failure in 18 (45%) patients, severe
anemia in 13 (32.5%) patients, cerebral malaria
in 5 patients (12.5%), acute respiratory distress
syndrome in 4 patients (10%), shock in 3 patients
(7.5%) and multi-organ dysfunction was detected
in 19 (47.5%) patients [16]. A study on young adult
females comparing the severe manifestations of Pv
malaria among pregnant (n = 25) and non-pregnant
(n = 144) groups found complications like severe
anemia (60% vs. 27%), hepatic failure (12% vs.
7.6%), renal failure (8% vs. 3.4%), ARDS (4% vs.
2.7%) and multiorgan dysfunction (4% vs. 3.4%)
more common in pregnant females [17]. There
is no larger study on pediatric patients regarding
severe manifestation of Pv malaria. A case series
by Parakh et al. of Pv malaria (n = 6) have shown
severe anemia (2 patients), altered renal functions
(2 patients) and cerebral malaria (3 patients) in
pediatric patients [25].
Our study highlights the fact that Pv can lead
to serious fatal complications similar to Pf. All
national and international guidelines should incor-
porate the term ‘‘severe vivax malaria’’ and
describe it further.
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